Our verdict
NewSelf advertises monthly equivalents for compounded GLP-1s under a policy requiring three months. Use the semaglutide price comparison to distinguish the cost of that commitment from a single-month purchase once the first debit is confirmed. Ask which pharmacy will dispense, when supplies ship and what stopping early would cost, since its public pages describe different shipment schedules.
Main trade-offs
- Three-month commitment behind the headline
- Upfront versus monthly shipment descriptions conflict
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
FDA warning letter on record — read the public record and the context below.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Buyers who are sure they'll stay at least three months and want a low compounded price that doesn't rise with the dose.
Consider other options if
Anyone who wants to try one month first, flexible cancellation, a brand-name drug, or service in Louisiana or Mississippi.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- Semaglutide as low as $99.97/mo, tirzepatide $144.49/mo; 3-month commitment, selected first debit confirm
- Medications
- Compounded semaglutide · Compounded tirzepatide
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- 48 states and Puerto Rico (not LA or MS)
- LegitScript
- Claimed by provider
Our review in detail
Full assessment
NewSelf advertises low monthly equivalents for compounded semaglutide and tirzepatide, but its policy requires a three-month commitment. Public pages disagree about whether medication arrives monthly or as a three-month supply. Confirm the actual first charge, shipment schedule and early-cancellation cost before comparing the headline with a one-month plan.
What it is
NewSelf Limited LLC is a technology platform that connects patients with independent providers; it says it doesn't offer medical or pharmacy services itself. Medical care is provided by NewSelf Affiliated P.C.s, and its partner page names MD Integrations, a physician network licensed in all 50 states, as its doctor network. The site lists a business address in Sheridan, Wyoming, while the FDA's letter went to an office in New York. NewSelf says it is a new company that treats more than 1,000 new patients a day and grows through referrals rather than advertising. It serves 48 states and Puerto Rico but not Louisiana or Mississippi. Besides weight loss, the site promotes longevity, brain-health and AI-assisted health-optimization products. It doesn't take insurance. It displays a LegitScript seal (ID 43278346). Its comparison chart against unnamed competitors is built partly from Reddit and review-site estimates, as its own footnote admits.
How care works
An online assessment is reviewed by a clinician, with medication shipped if prescribed. The partner page names Beaker Pharmacy, Pharmaneek and Logos RX as possible partners, without assigning a specific order. Free overnight shipping is advertised, separate from clinical and pharmacy preparation. The home page and payment policy describe three months supplied upfront, while product pages say monthly delivery; obtain the schedule for your prescription. State eligibility, labs and pharmacy assignment remain patient-specific.
Costs, billing and cancellation
The visible home and product pages advertise semaglutide as low as $99.97/month and tirzepatide as low as $144.49/month, with the same price at all doses claimed. The Oak Longevity review shows why a starting price needs checking: Oak advertises weight care from $109 a month without naming the drug or term. The payment policy requires a three-month commitment and offers interest-free monthly payments. Those monthly headlines do not establish the actual first debit or full selected plan charge.
The policy says cancellation before the doctor consultation may receive a refund less $99; after consultation, no refund is promised even before shipment. Clinical rejection is described as fully refundable. Early cancellation can be charged at the full retail monthly program price, which is not fixed by the headline. A prescription-change reprocessing fee is $150. Wrong or damaged shipments must be reported within seven days. The public fulfillment descriptions conflict, so confirm both billing and shipment terms before enrolling.
Medication and evidence
Compounded semaglutide with vitamin B12 or glycine and compounded tirzepatide with vitamin B6 or glycine, both weekly injections. No brand-name GLP-1 is sold. The site states that the medications are compounded by licensed pharmacies, aren't FDA-approved, and that no claim is made that they are equivalent to an FDA-approved product. Its partner page, dated September 2025, names Beaker Pharmacy in McKinney, Texas; Pharmaneek Pharmacy Services in Indianapolis; and Logos RX in Tampa. It says its 503A pharmacies use independent third-party testing for potency, sterility and endotoxins. The added vitamins and glycine aren't backed by trial evidence of better weight loss, and the outcome figures on the homepage come from its own members or from brand-name trials. In February 2026 the FDA sent NewSelf a warning letter after reviewing its website in December 2025. The agency said product images labeled "NewSelf" suggested the company was the compounder, and cited claims such as "Same active ingredient as Ozempic® & Wegovy®" that implied FDA approval. The letter is disclosed and linked on this page.
FDA warning letter on record
The FDA issued a warning letter naming NewSelf Limited dba NewSelf, the company behind NewSelf.
- Letter 721472, issued February 20, 2026 — read it on fda.gov
We publish this because it is a matter of public record and a reader weighing this provider should have it. A warning letter is the FDA setting out alleged violations; it is not a court finding, and a company may have responded or corrected since. It does not remove NewSelf from this site, and it does not change our verdict — read the letter and decide for yourself.
Pros and watch-outs
What we like
- Low monthly equivalents advertised at all doses
- Possible pharmacy partners named
- Monthly payment option described
Watch-outs
- Three-month commitment behind the headline
- Upfront versus monthly shipment descriptions conflict
- Post-consultation refunds are restricted
- Early-cancel retail charge and first debit need confirmation
Best for
Buyers who are sure they'll stay at least three months and want a low compounded price that doesn't rise with the dose.
Who should look elsewhere
Anyone who wants to try one month first, flexible cancellation, a brand-name drug, or service in Louisiana or Mississippi.
Research relevant to NewSelf
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
SURMOUNT-5 found 20.2% versus 13.7% average weight loss. What that direct comparison supports, which doses it tested, and why newer formulations need separate evidence.
- Compounded vs branded GLP-1: regulatory status, sourcing and the evidence
Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.
How NewSelf compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our Belle review and Embody review describe what each service publishes about pricing, billing and cancellation.
BellePeople who want a flat price that doesn't rise with the dose and regular dietitian check-ins
See Belle →Embody
People comfortable prepaying a long plan for a low monthly rate that does not rise with dose
See Embody →
Mint MedCash buyers in a confirmed served state who want a low posted monthly rate and can meet the cancellation cutoff
See Mint Med →
More GLP-1 telehealth reviews: RiovieGreen Cap HealthRoenRxMaven ClinicBayan HealthGaya Wellness
Research & data
How we assessed this. This review is based on NewSelf’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is NewSelf a one-month plan?
- Its policy requires a three-month commitment, despite monthly-equivalent headlines of $99.97 for semaglutide and $144.49 for tirzepatide. Confirm the total and first debit.
- Does NewSelf ship three months at once?
- The home page and policy describe three months upfront, but product pages say monthly delivery. Get the fulfillment schedule for your selected prescription in writing.
- Can I cancel NewSelf?
- Before the doctor consultation, a refund may be reduced by $99; after consultation, the policy generally denies refunds. Early cancellation may trigger full retail pricing. Clinical rejection is described as fully refundable.
- Which pharmacy does NewSelf use?
- Its partner page names Beaker Pharmacy, Pharmaneek and Logos RX. That list does not establish which one fills your prescription.
- Is NewSelf legit?
- FDA has a warning letter on record against NewSelf Limited dba NewSelf, the company behind NewSelf, issued February 20, 2026 as letter 721472; it is linked further down this page. A warning letter is a public record worth reading. It doesn't by itself mean you can't use this provider. NewSelf is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. Its stated availability: 48 states and Puerto Rico (not LA or MS). What it publishes up front: Semaglutide as low as $99.97/mo, tirzepatide $144.49/mo; 3-month commitment, selected first debit confirm. It is cash-pay and states it does not bill insurance. It shows a LegitScript seal. Ask the company for its certificate number before you rely on it. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees.
